Catalyst Wire Dossier Catalyst Wire Dossier

Tacrolimus Ointment (0.1%)

tacrolimus · Astellas Pharma
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Tacrolimus Ointment (0.1%), covering 2014-09-05 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis [Phase 4]

See pricing